Our results are consistent with Peng et al.23, who showed that the lncRNA HULC is a novel biomarker in patients with pancreatic cancer and diffuse large B-cell lymphoma.24 This indicates that HULC may have potential as a biomarker in EOC diagnosis. This evidence concerns the gene HULC and familial pancreatic carcinoma.